Sentence examples for most prevalent observed from inspiring English sources

Chronic lung disease was the most prevalent, observed for approximately 20% of the influenza/ILI episodes, at every age.

Dementia is the most prevalent, observed in 47%–78% of residents (Rovner et al 1990; DeVane and Mintzer 2003).

Within the investigated group, the expression of both TTF-1 and MAdL comprised about 25 cases (14.9%) and was the second most prevalent observed pattern.

In position P1', glycine (G), serine (S), cysteine (C), alanine (A) and arginine (R) were among the most prevalent residues observed, all known to generate functional TEVp substrates and largely in line with other published studies stating that there is a strong preference for short aliphatic residues in this position.

Moreover, in position P1', glycine (G), serine (S), cysteine (C), alanine (A) and arginine (R) were among the most prevalent residues observed, all known to generate functional TEVp substrates and in line with other studies stating that there is a strong preference for short aliphatic residues in this position.

Halogenation by means of chlorination is the most prevalent modification observed in GPA scaffolds.

In the qualitative section, non-transparency of management, lack of goals, administrative problems were among the most prevalent issues observed.

The most prevalent mutation observed in 22 patients (11 %) was BRCA1 c.5263_5264insC, a known Slavic mutation with founder effect in Eastern European and AJ communities.

The most prevalent mutation observed in 22 patients (11 %) was BRCA1 c.5263_5264insC, a known Slavic mutation with founder effect in Eastern European as well as AJ communities, (Table  2).

Sequence types 5 (21.3% of all carriers), 30 (18% of all carriers) and 8 (16.4% of all carriers) were the most prevalent STs observed within the cohort (Table  2).

Anti-nuclear antibodies (ANA) and dsDNA antibodies were the most prevalent autoantibodies observed in these SLE cohorts as determined by ELISA, which were detected in 100% (95/95) and 82.1% (78/95) of SLE patients, respectively (Table 3).